AC-708

N/A

Report date: 2022/10/14 20:00:43

Base Information

Drug NameAC-708
Drug Alias NamePLX-73086AC-708
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 1 receptor inhibitors
TargetsColony stimulating factor 1 receptor
Therapy Area/IndicationsSolid tumoursSynovitis, Pigmented VillonodularGiant Cell Tumor of Tendon Sheath
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPlexxikon Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursSynovitis, Pigmented VillonodularGiant Cell Tumor of Tendon Sheath

Other Information

ATC CodeN/A
Related LinksN/A